Machine-Learning Algorithm for Predicting Fatty Liver Disease in a Taiwanese Population
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine-Learning Algorithm for Predicting Fatty Liver Disease in a Taiwanese Population
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 12, Issue 7, Pages 1026
Publisher
MDPI AG
Online
2022-06-24
DOI
10.3390/jpm12071026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and validation of a deep learning-based algorithm for colonoscopy quality assessment
- (2022) Yuan-Yen Chang et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Importance of sex and gender factors for COVID-19 infection and hospitalisation: a sex-stratified analysis using machine learning in UK Biobank data
- (2022) Zahra Azizi et al. BMJ Open
- Estimation of Human Cerebral Atrophy Based on Systemic Metabolic Status Using Machine Learning
- (2022) Kaoru Sakatani et al. Frontiers in Neurology
- Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study
- (2022) Byoungduck Han et al. Diagnostics
- A Machine Learning Based Framework to Identify and Classify Non-alcoholic Fatty Liver Disease in a Large-Scale Population
- (2022) Weidong Ji et al. Frontiers in Public Health
- Use of Multi-Modal Data and Machine Learning to Improve Cardiovascular Disease Care
- (2022) Saeed Amal et al. Frontiers in Cardiovascular Medicine
- Machine Learning-Based Surgical Planning for Neurosurgery: Artificial Intelligent Approaches to the Cranium
- (2022) Tolga Turan Dundar et al. Frontiers in Surgery
- Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
- (2022) Sina Ghandian et al. JGH Open
- Machine Learning Algorithms for Predicting Fatty Liver Disease
- (2021) Xieyi Pei et al. ANNALS OF NUTRITION AND METABOLISM
- Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study
- (2021) Hsu-Heng Yen et al. BMC GASTROENTEROLOGY
- Performance Comparison of the Deep Learning and the Human Endoscopist for Bleeding Peptic Ulcer Disease
- (2021) Hsu-Heng Yen et al. Journal of Medical and Biological Engineering
- Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients
- (2021) Hsu-Heng Yen et al. PeerJ
- Fatty Liver Disease Prediction Model Based on Big Data of Electronic Physical Examination Records
- (2021) Mingqi Zhao et al. Frontiers in Public Health
- Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study
- (2021) Yuan-Xing Liu et al. Hepatobiliary & Pancreatic Diseases International
- Current Status and Future Perspective of Artificial Intelligence in the Management of Peptic Ulcer Bleeding: A Review of Recent Literature
- (2021) Hsu-Heng Yen et al. Journal of Clinical Medicine
- Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers
- (2021) Roshan Shafiha et al. Biomedicines
- Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
- (2021) Amporn Atsawarungruangkit et al. World Journal of Hepatology
- Glecaprevir–pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting
- (2020) Hsu-Heng Yen et al. PLoS One
- Hepatic steatosis and patients with inflammatory bowel disease
- (2019) Cátia Arieira et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Unexpected Rapid Increase in the Burden of Nonalcoholic Fatty Liver Disease in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
- (2019) Feng Zhou et al. HEPATOLOGY
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- Noninvasive and Convenient Screening of Metabolic Syndrome Using the Controlled Attenuation Parameter Technology: An Evaluation Based on Self-Paid Health Examination Participants
- (2019) Yu-Jiun Lin et al. Journal of Clinical Medicine
- Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography
- (2018) Chiara Saroli Palumbo et al. INFLAMMATORY BOWEL DISEASES
- Predicting hepatic steatosis in living liver donors via controlled attenuation parameter
- (2018) Yi-Hao Yen et al. TRANSPLANTATION PROCEEDINGS
- Reducing NAFLD screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans
- (2018) Filippo Procino et al. LIVER INTERNATIONAL
- Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China
- (2018) Han Ma et al. Biomed Research International
- Prediction of fatty liver disease using machine learning algorithms
- (2018) Chieh-Chen Wu et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Changing shape of disease: Nonalcoholic fatty liver disease in Crohnʼs disease—A case series and review of the literature
- (2011) Christopher E. McGowan et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More